key: cord-0730279-ruwa45ic
authors: Vesely, Matthew D.; Perkins, Sara H.
title: Caution in the time of rashes and COVID-19
date: 2020-07-15
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.07.026
sha: 014214290a970767d3de5aac7eb1b22db4e91f02
doc_id: 730279
cord_uid: ruwa45ic

nan

. It remains to be determined which skin manifestations are a sign of SARS-CoV-2 infection due to direct tissue injury from viral tropism or sequela of infection such as coagulopathy and immune injury. 3 We recommend caution when concluding that cutaneous findings are specifically due to SARS-CoV-2. Without question, SARS-CoV-2 is a unique and devastating virus with multiple tissue tropism and heterogeneous immune activation. With further clinical studies, more widespread testing and a better understanding of the natural course of the virus, these skin manifestations will likely settle into two types: virus-specific and non-specific. To determine virus-specific mechanisms, direct detection of viral particles within cutaneous lesions is needed. 3 Furthermore, these studies should use control tissue of similar lesions (e.g. perniosis) that occurred prior to the pandemic. In the absence of direct viral detection, unique immune Although distinct in etiology, disease course and treatment, the lessons learned from studying SLE may be applied to understanding the cutaneous manifestations of COVID-19. In 1992, Dr.

Robert A. Greenwald commented that "anything happening to a patient with SLE which is not immediately otherwise explicable will automatically be blamed on the lupus, regardless of pathophysiologic validity" 4 . This became known as Greenwald's law of lupus. Subsequently, Dr.

Richard Sontheimer provided a corollary to Greenwald's law that anything happening to patient with a positive anti-nuclear antibody will be blamed on lupus 5 . Now it appears that anything happening to a patient's skin during the COVID-19 pandemic will be attributed to SARS-CoV-2 infection, rightly or wrongly.

Cutaneous Manifestations of COVID-19: A Preliminary Review

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases

Greenwald's law of lupus

Greenwald's law of lupus: the Sontheimer amendment

These skin findings have been reported by clinicians as potential signs of COVID-19. Most of these highly variable and rare findings reported in case reports and small case series may not be specific to SARS-CoV-2 infection. We urge caution and continued scholarship moving forward to decipher what impact COVID-19 has on skin